Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnanda Developments Plc Regulatory News (ANA.PL)

Share Price Information for Ananda Developments Plc (ANA.PL)

Aquis Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.315
Bid: 0.28
Ask: 0.35
Change: 0.00 (0.00%)
Spread: 0.07 (25.00%)
Open: 0.315
High: 0.315
Low: 0.315
Prev. Close: 0.315
ANA.PL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor Presentation via Investor Meet Company

8 Nov 2023 07:30

RNS Number : 6884S
Ananda Developments PLC
08 November 2023

8 November 2023

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

Investor Presentation via Investor Meet Company

Ananda Developments Plc ('Ananda') is pleased to announce that Melissa Sturgess, Chief Executive Officer, will provide a live presentation update on Ananda via Investor Meet Company on Tuesday 14th November at 9:00am GMT. The presentation follows the Company's recent announcements and Investival Showcase presentation in London on Monday 13th November.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet ANANDA DEVELOPMENTS PLC via:

https://www.investormeetcompany.com/ananda-developments-plc/register-investor

Investors who already follow ANANDA DEVELOPMENTS PLC on the Investor Meet Company platform will automatically be invited.

The video will also be available for viewing after the event on the Company's website and YouTube channel (https://www.youtube.com/@anandadevelopmentsplc7440).

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:

· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=

· LinkedIn: https://www.linkedin.com/company/anadevelopments/

· Twitter: https://twitter.com/anandaplc?s=21&t=9yeIC_xYCfzgDn7j26sfuA

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC

+44 (0)7463 686 497

ir@anandadevelopments.com

Chief Executive Officer

Melissa Sturgess

Executive Director

Jeremy Sturgess-Smith

SP ANGEL CORPORATE FINANCE LLP

+44 (0)20 3470 0470

Corporate Finance

Richard Morrison

Harry Davies-Ball

Corporate Broking

Abigail Wayne

Rob Rees

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

For more information, please visit: https://anandadevelopments.com/

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABLBDBXDGDGXR
Date   Source Headline
2nd May 202412:00 pmRNSResponse to FSA-FSS Cannabidiol Safety Assessment
21st Mar 20247:00 amRNSEstablishment of Scientific Advisory Board
28th Feb 20247:00 amRNSEndometriosis Trial Drug Supply Agreement Signed
26th Feb 202412:00 pmRNSAnanda presenting at Master Investor Show
26th Feb 20247:00 amRNSQuarterly Trading Statement to 31 January 2024
6th Feb 20247:00 amRNSAppointment of Adviser
23rd Jan 20247:00 amRNSAppointment of Scientific Advisers
14th Dec 20237:00 amRNSAnanda Launches New Interactive Investor Hub
29th Nov 20232:39 pmRNSQuarterly Trading Statement to 31 October 2023
14th Nov 20237:00 amRNSDrug Supply Agreement Signed
8th Nov 20237:30 amRNSInvestor Presentation via Investor Meet Company
8th Nov 20237:00 amRNSTHC Oil Patent Application Filed
1st Nov 20237:00 amRNSMOU signed with Nottingham Trent University
24th Oct 20232:20 pmRNSInterim Results to 31 July 2023
6th Sep 20237:00 amRNSIssue of Convertible Loan Notes
31st Aug 20237:00 amRNSShareholder Update
25th Aug 202312:01 pmRNSResearch Roundup
24th Aug 20232:28 pmRNSResult of AGM
15th Aug 20237:00 amRNSNHS SCOTLAND TO FUND MRX1 ENDOMETRIOSIS TRIAL
31st Jul 20235:44 pmRNSCompletion of Audit & Notice of AGM
27th Jul 20237:00 amRNSFirst Cannabinoid Medicines Launched
13th Jul 202310:22 amRNSUnaudited Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.